Effect of Balaharidradi Lepa in Vyanga (Melasma).

A Randomized clinical trial for the evaluation of Balaharidradi Lepa in Vyanga (Melasma).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018722

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Balaharidradi Lepa: 5gm once a day for external application, 2 months Control Intervention1: Balaharidradi Lepa with Khadira Kwath: Balaharidradi lepa -5gm once a day for external appli

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting Vyanga in clinical features

Exclusion criteria

Exclusion criteria: 1. With present history of skin disease e.g. psoriasis, dermatitis, vitiligo etc. related to face. 2. Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid. 3. Patients of uncontrolled hormonal disease. 4. Any kind of hereditary skin disorder. 5. Incurable skin diseases mentioned in Ayurveda Samhita. 6. With present history of pregnancy and chronic constipation.

Design outcomes

Primary

Measure	Time frame
Reduction in symptoms of Vyanga.Timepoint: baseline, 15 days, 30 days, 45 days, 60 days	—

Secondary

Measure	Time frame
Measurement of Vyanga (Melasma) severityTimepoint: baseline, 15 days, 30 days, 45 days, 60 days	—

Countries

India

Contacts

Public ContactSukha ram

National Institute of Ayurveda, Jaipur

mita@ayu.in9414078872

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026